Suppr超能文献

“我应该让他们知道我有这个病吗?”:遗传性癌症综合征患者面临的多方面基因歧视及对法律保护的认知有限

"Should I Let Them Know I Have This?": Multifaceted Genetic Discrimination and Limited Awareness of Legal Protections among Individuals with Hereditary Cancer Syndromes.

作者信息

Gopalakrishnan Ridhi, Sam Jordan, Butkowsky Carly, Reble Emma, Clausen Marc, Rajeziesfahani Sepideh, Sparkes Brooklyn, Aguda Vernie, Aronson Melyssa, Bishop Derrick, Dawson Lesa, Eisen Andrea, Graham Tracy, Green Jane, Mighton Chloe, Pauling Julee, Pavao Claudia, Pechlivanoglou Petros, Remocker Catriona, Savas Sevtap, Sun Sophie, Tiano Teresa, Tilley Angelina, Schrader Kasmintan, Etchegary Holly, Bombard Yvonne

机构信息

Genomics Health Services Research Program, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

出版信息

Public Health Genomics. 2024;27(1):240-254. doi: 10.1159/000542210. Epub 2024 Oct 24.

Abstract

INTRODUCTION

Hereditary cancer syndromes (HCS), such as hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome (LS), represent approximately 10% of all cancers. Along with medical burdens associated with the genetic risk of developing cancer, many individuals face stigma and discrimination. Genetic discrimination refers to negative treatment, unfair profiling, or harm based on genetic characteristics, manifesting as "felt" stigma (ostracization without discriminatory acts) or "enacted" stigma (experiencing discriminatory acts). This study aimed to describe concerns and experiences of genetic discrimination faced by individuals with HCS.

METHODS

Semi-structured qualitative interviews were conducted with individuals with molecularly confirmed HCS residing in Ontario, British Columbia, and Newfoundland and Labrador, Canada. Purposive sampling was applied to obtain a diverse sample across demographic characteristics. Study procedures were informed by interpretive description; data were thematically analyzed using constant comparison.

RESULTS

Seventy-three participants were interviewed (39 HBOC, 34 LS; 51 females, 21 males, 1 gender-diverse; aged 25-80). Participants described multifaceted forms of genetic discrimination across healthcare, insurance, employment, and family/social settings. Participants valued the Genetic Nondiscrimination Act's protective intent but demonstrated limited knowledge of its existence and provisions. Limited knowledge, coupled with policy constraints in non-legislative settings and third-party use of proxy genetic information, hindered participants' ability to whistleblow or seek recourse.

CONCLUSION

Our results illuminate a disconnection between the intended protective effects of genetic nondiscrimination legislation and ongoing genetic discrimination faced by individuals with hereditary conditions. To better support these individuals, this study encourages public outreach and knowledge translation efforts to increase awareness of nondiscrimination legal protections.

摘要

引言

遗传性癌症综合征(HCS),如遗传性乳腺癌和卵巢癌综合征(HBOC)以及林奇综合征(LS),约占所有癌症的10%。除了与患癌遗传风险相关的医疗负担外,许多人还面临耻辱和歧视。基因歧视是指基于遗传特征的负面对待、不公平定性或伤害,表现为“感知到的”耻辱(无歧视行为的排斥)或“实施的”耻辱(经历歧视行为)。本研究旨在描述遗传性癌症综合征患者所面临的基因歧视相关担忧和经历。

方法

对居住在加拿大安大略省、不列颠哥伦比亚省以及纽芬兰和拉布拉多省且经分子确诊患有遗传性癌症综合征的个体进行了半结构化定性访谈。采用目的抽样法以获取涵盖不同人口统计学特征的多样化样本。研究程序以诠释性描述为依据;使用持续比较法对数据进行主题分析。

结果

共访谈了73名参与者(39名HBOC患者,34名LS患者;51名女性,21名男性,1名性别多元者;年龄在25 - 80岁之间)。参与者描述了在医疗保健、保险、就业以及家庭/社会环境中基因歧视的多方面形式。参与者重视《基因非歧视法案》的保护意图,但对其存在和条款的了解有限。知识的匮乏,加上非立法环境中的政策限制以及第三方对代理基因信息的使用,阻碍了参与者举报或寻求补救的能力。

结论

我们的研究结果揭示了基因非歧视立法的预期保护效果与遗传性疾病患者所面临的持续基因歧视之间的脱节。为了更好地支持这些个体,本研究鼓励开展公众宣传和知识转化工作,以提高对非歧视法律保护的认识。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验